Human Genome Sciences Closed Tuesday At Second Consecutive New High For Year

Posted on: Wed, 04 Nov 2009 08:31:00 EST


Symbols: HGSI
(RTTNews) - Human Genome Sciences (HGSI | Quote | Chart | News | PowerRating) traded to the upside for the majority of Tuesday's session, but was range-bound during the final 2 hours of the afternoon. The stock closed higher by $2.79 at $28.07 on above average volume.

Human Genome Sciences and GlaxoSmithKline PLC (GSK | Quote | Chart | News | PowerRating) announced Monday morning that BENLYSTA met the primary endpoint in the second of two Phase 3 trials in seropositive patients with systemic lupus erythematosus. Human Genome Sciences closed Tuesday at its second consecutive new high for the year.

For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved

For full details on Human Genome Sciences (HGSI) HGSI. Human Genome Sciences (HGSI) has Short Term PowerRatings at TradingMarkets. Details on Human Genome Sciences (HGSI) Short Term PowerRatings is available at This Link.